Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02RIE
|
||||
Former ID |
DNC007932
|
||||
Drug Name |
4-(2,4-dichlorophenyl)-1-tosylpyrrolidin-3-amine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H18Cl2N2O2S
|
||||
Canonical SMILES |
CC1=CC=C(C=C1)S(=O)(=O)N2CC(C(C2)N)C3=C(C=C(C=C3)Cl)Cl
|
||||
InChI |
1S/C17H18Cl2N2O2S/c1-11-2-5-13(6-3-11)24(22,23)21-9-15(17(20)10-21)14-7-4-12(18)8-16(14)19/h2-8,15,17H,9-10,20H2,1H3
|
||||
InChIKey |
XFWVFJXNYYSICX-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Dipeptidyl peptidase IV | Target Info | Inhibitor | [1] | |
KEGG Pathway | Protein digestion and absorption | ||||
NetPath Pathway | IL2 Signaling Pathway | ||||
TGF_beta_Receptor Signaling Pathway | |||||
References | |||||
REF 1 | Bioorg Med Chem Lett. 2007 Apr 1;17(7):2005-12. Epub 2007 Jan 19.Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.